Gary W. Pace, Director of Cardiff Oncology CRDF, has filed 7 purchases and 4 sales on the open market. Over the past 12 months that comes to a net purchase of $36.6K. The latest trade was on 06/18.

GP

GP

Gary W. Pace

Director

Company

Cardiff Oncology CRDF

First filing

23/05/15

Trades

19 trades

Buys / sales

7 / 4

12-month net buying

$36.6K

Last trade

06/18

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Cardiff OncologyCRDF	Open-market buy	06/18	06/22	30,000 sh	$1.22	$36,600	+2.3%
Cardiff OncologyCRDF	Open-market buy	25/07/30	25/07/31	290,000 sh2 trades	$2.45avg.	$710,500	No record
Cardiff OncologyCRDF	Open-market buy	24/12/11	24/12/12	361,615 sh2 trades	$2.60avg.	$940,199	No record
Pacira BioSciencesPCRX	Open-market sale	24/03/06–24/03/08	24/03/08	119,323 sh3 trades	$30.64avg.	$3,656,226.39	−84.4%
Cardiff OncologyCRDF	Open-market buy	23/12/19	23/12/19	30,000 sh	$1.37	$41,100	+4.5%
Cardiff OncologyCRDF	Open-market buy	23/11/10	23/11/14	22,950 sh	$0.98	$22,491	+3.6%
Pacira BioSciencesPCRX	Open-market sale	23/05/11	23/05/15	5,015 sh	$41.78	$209,526.7	−3.5%